Tumour Treating Fields for mesothelioma - Authors' reply

Lancet Oncol. 2020 Jan;21(1):e10. doi: 10.1016/S1470-2045(19)30831-9.

Authors

Giovanni L Ceresoli¹, Letizia Gianoncelli², Federica Grosso³; STELLAR investigators

Affiliations

¹ Department of Oncology, Cliniche Humanitas Gavazzeni, 24125 Bergamo, Italy. Electronic address: [email protected].
² Department of Oncology, Cliniche Humanitas Gavazzeni, 24125 Bergamo, Italy; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milano, Italy.
³ Mesothelioma Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.

PMID: 31908296
DOI: 10.1016/S1470-2045(19)30831-9

No abstract available

Publication types

Letter
Comment

MeSH terms

Carboplatin
Cisplatin
Humans
Lung Neoplasms*
Mesothelioma*
Pemetrexed

Substances

Pemetrexed
Carboplatin
Cisplatin